Toward a Safe and Reachable Preventive Therapy for LTBI: a Multicenter Randomized Controlled Study in Taiwan

NCT02208427 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

283

Enrollment

OTHER

Sponsor class

Conditions

Latent Tuberculosis Infection

Interventions

DRUG: Rifapentine and Isoniazid for 3 months
DRUG: Isoniazid for 9 months

Sponsor

National Taiwan University Hospital